healthfinch to grow with $7.5M in Series A funding

healthfinch, the healthcare IT company behind the award-winning application Swoop for prescription refill requests, has secured $7.5 million in Series A financing to build out its practice automation platform, “Charlie.”

Investment firm Adams Street Partners led the round, with participation from JumpStart Ventures, Chicago Ventures, OCA Ventures, Abundant Ventures and a private investor. This financing round brings healthfinch’s total raise to over $10 million since CEO Jonathan Baran, MS, and CMO Lyle Berkowitz, MD, founded the company in 2011.

“The rapid adoption and demand from health systems for Swoop is a clear indication that automating routine and repeatable tasks is the future of healthcare delivery,” said Baran in a release. “To this end, we’re moving beyond individual applications in favor of a robust practice automation platform that can handle many more tasks beyond prescription refill requests including visit planning, patient communication and much more.”

Tom Bremner, a partner at Adams Street, cited healthfinch’s “winning trifecta” of “strong clinical and executive leadership, a compelling product roadmap that will bring clear value to the healthcare system, and most importantly, clients who have been using healthfinch products to achieve up to 5 times efficiency and financial ROI.”

The Series A funds will be used to augment healthfinch’s technical and clinical teams to accelerate development of the Charlie platform and expedite delivery to health systems, according to Baran.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup